Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by menoalittleon Dec 04, 2021 12:00pm
241 Views
Post# 34198416

RE:RE:RE:Great volume continues

RE:RE:RE:Great volume continues>> The clinical trial data was released in a low key way...

ah.... yeah.  No doubt about it. Fact is, it wasn't just the clinical trial data.  It started with the Nov. 15th news release, if you really think about it.  What was and wasn't said... how it was said... 

If/when you start pondering the why's and wherefore's and connecting dots of the little bits and pieces... well, perhaps it's why I'm inclined to think that the vast majority of recent buying (ever since that November news release) has been those that have already had eyes on this. Some have simply caught on to it (or rather, up to it) a bit quicker than others, and have been accumulating as much or as fast as they can, as best they can... because they know this is still flying well under the radar of most of the rest of the market (although, the last day or two may have started a change to that... Monday/Tuesday will be a tell whether they're on to us yet or not.)
 
<< Previous
Bullboard Posts
Next >>